Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D

American Journal of Kidney Diseases

Volumn 64, Issue 5, 2014, Pages 770-780

  Yusuf, Akeem A ^a,b   Howell, Benjamin L ^c   Powers, Christopher A ^c   St Peter, Wendy L ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

calcimimetics; dialysis; Index Words Chronic kidney disease (CKD); Medicare Part D; medication costs; mineral and bone disorder; phosphate binders; vitamin D analogues

Indexed keywords

CALCITRIOL; CALCIUM ACETATE; CALCIUM CARBONATE; CINACALCET; DOXERCALCIFEROL; GENERIC DRUG; LANTHANUM CARBONATE; NON PRESCRIPTION DRUG; PARICALCITOL; PHOSPHATE BINDING AGENT; PRESCRIPTION DRUG; SEVELAMER; SEVELAMER CARBONATE; VITAMIN D; NAPHTHALENE DERIVATIVE; PHOSPHATE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE DISEASE; CHRONIC KIDNEY DISEASE; COST OF ILLNESS; DRUG COST; DRUG UTILIZATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMODIALYSIS PATIENT; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTPATIENT CARE; ADOLESCENT; BONE DISEASES; ECONOMICS; EPIDEMIOLOGY; MIDDLE AGED; POVERTY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE DISEASES; DRUG UTILIZATION; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MEDICARE PART D; MIDDLE AGED; NAPHTHALENES; PHOSPHATE-BINDING PROTEINS; POVERTY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; VITAMIN D; YOUNG ADULT;

EID: 84908488249     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.014     Document Type: Article

References (15)

1. KDIGO CKD-MBD Workgroup KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl 113 2009 S1 S130
2. S.M. Moe, T. Drueke, N. Lameire, and G. Eknoyan Chronic kidney disease-mineral-bone disorder: a new paradigm Adv Chronic Kidney Dis 14 1 2007 3 12
3. A.J. Collins, R.N. Foley, and C. Herzog US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 e1 e480
4. K. Kalantar-Zadeh, A. Shah, U. Duong, R.C. Hechter, R. Dukkipati, and C.P. Kovesdy Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals Kidney Int Suppl 117 2010 S10 S21
5. A.B. Pai, and B.M. Shepler Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications Pharmacotherapy 29 5 2009 554 561
6. D.L. Frankenfield, E.D. Weinhandl, C.A. Powers, B.L. Howell, C.A. Herzog, and W.L. St. Peter Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D Am J Kidney Dis 59 5 2012 670 681
7. N.C. Sacks, J.F. Burgess Jr., H.J. Cabral, S.D. Pizer, and M.E. McDonnell Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries J Gen Intern Med 28 7 2013 876 885
8. B.L. Howell, C.A. Powers, E.D. Weinhandl, W.L. St Peter, and D.L. Frankenfield Sources of drug coverage among Medicare beneficiaries with ESRD J Am Soc Nephrol 23 5 2012 959 965
9. M. Wolf, J. Betancourt, and Y. Chang Impact of activated vitamin D and race on survival among hemodialysis patients J Am Soc Nephrol 19 7 2008 1379 1388
10. K. Kalantar-Zadeh, J.E. Miller, and C.P. Kovesdy Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients J Bone Miner Res 25 12 2010 2724 2734
11. A. Gupta, L.R. Kallenbach, G. Zasuwa, and G.W. Divine Race is a major determinant of secondary hyperparathyroidism in uremic patients J Am Soc Nephrol 11 2 2000 330 334
12. B.B. Newsome, R.D. Kilpatrick, and J. Liu Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients Am J Nephrol 38 2 2013 104 114
13. E.D. Weinhandl, T.J. Arneson, and W.L. Peter Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report Am J Kidney Dis 62 3 2013 557 567
14. MediSpan. PriceChek PC (R): a Drug Database by MediSpan (Indianapolis, IN), a Division of Wolters Kluwer Health, Inc 2013 Wolters Kluwer Health, Inc Indianapolis, IN
15. G.M. Allan, J. Lexchin, and N. Wiebe Physician awareness of drug cost: a systematic review PLoS Med 4 9 2007 e283